A carregar...
Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches
The α-emitting radionuclide actinium-225 possesses nuclear properties that are highly promising for use in targeted α therapy (TAT), a therapeutic strategy that employs α particle emissions to destroy tumors. A key factor, however, that may hinder the clinical use of actinium-225 is the poor underst...
Na minha lista:
| Publicado no: | Cancer Biother Radiopharm |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Mary Ann Liebert, Inc., publishers
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6207149/ https://ncbi.nlm.nih.gov/pubmed/29889562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2018.2494 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|